Fact CheckerSign in

NCT04541654Recruiting

Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

Li-Fraumeni & TP53: Understanding and Progress (LiFT UP)

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

The purpose of this research study is to learn more about variants in the TP53 gene both associated with Li-Fraumeni Syndrome (LFS), a hereditary cancer risk condition, and TP53 variants found in the blood for other reasons (e.g. ACE/CHIP and mosaicism).

Status (registry)
Recruiting
Study type
Observational
Enrollment
1500 (estimated)
First submitted
25 Aug 2020
Start date
15 Sept 2020
Primary completion date
31 Dec 2030
Lead sponsor
Dana-Farber Cancer Institute
NCT number
NCT04541654

What you commit to

  • Study type: Observational
  • Planned participants: 1500
  • From 15 Sept 2020 to the primary completion date, 31 Dec 2030
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Individuals who decline to sign consent
  • Individuals who are unable to give consent or assent and are without a designated healthcare proxy

Who the study is looking for

  • Individuals with a TP53 pathogenic or likely pathogenic variant identified in blood or saliva,
  • Individuals with variants of uncertain significance in TP53 may be eligible at the PI's discretion,
  • Blood relatives of individuals with a TP53 variant, who may be presumed obligate carriers or healthy controls,
  • Individuals who meet Classic or Chompret LFS criteria whether or not they have a TP53 gene variant,
  • Individuals may enroll their deceased relatives in the study.
  • Individuals with a known TP53 variant that is not LFS, but rather ACE, CHIP, or mosaicism.
  • Individuals participating in other LFS studies can still enroll in LiFT UP. Investigators may be collaborators.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Boston Children's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
Judy E. Garber
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
Brigham and Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.